ClinicalTrials.gg
Not yet recruitingNCT07646990Updated Jun 15, 2026

Carbohydrate or Protein Drinks Before Exercise in the Heat

An interventional study of Protein shake and Carbohydrate shake in Heat Stress, Diet Induced Thermogenesis and Protein Consumption, sponsored by Providence College. Not yet recruiting. Open to participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-15.

Sponsored by Providence College · Not applicable, Interventional, and Prevention

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
16
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
All
01

Study summary

This project examines whether consuming a high-protein or high-carbohydrate beverage before exercise in the heat impacts metabolism and heat balance during exercise, with the following research questions:

  1. Does a high-protein vs. high-carbohydrate pre-exercise drink impact metabolism and body temperature responses during a treadmill walking in the heat?
  2. Does a high-protein or high-carbohydrate drink change oxygen use and heat production during treadmill walking in the heat?
02

Conditions studied

  • Heat Stress
  • Diet Induced Thermogenesis
  • Protein Consumption

Keywords

  • high protein diet, exercise, hot environment
03

In context

Heat Stress Disorders

118 studies on the registry are indexed under Heat Stress Disorders; 42 are open to participants now.

This study's planned enrollment of 16 is below the median of 24 across 104 interventional studies indexed under Heat Stress Disorders.

Browse Heat Stress Disorders studies →

Lead sponsor

Providence College is the lead sponsor of 4 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Able to walk or run up to 5 mph on a treadmill
  • Able to consume products containing dairy (no allergy or dietary restrictions)

Exclusion criteria

Exclusion Criteria:

  • Following a diet that excludes any macronutrient group (low-carb or low-fat)
  • Diagnosed cardiovascular or metabolic diseases (hypertension, diabetes)
  • Diagnosed heat illness in past 3 months (heat exhaustion, heat stroke)
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
16 participants (estimated)

Study arms

  • Experimental
    High Protein

    A 22-oz high-protein, low-carbohydrate shake (chocolate flavor), given 60-90 minutes before exercise.

    Dietary Supplement: Protein shake

  • Active comparator
    High Carbohydrate

    A 22-oz, high-carbohydrate, low-protein \& fat shake (chocolate flavor), given 60-90 minutes before exercise

    Dietary Supplement: Carbohydrate shake

Interventions

  • Dietary supplementProtein shake

    22 oz of a beverage containing 320 kilocalories (60g protein, 6g fat, 8g carbohydrate).

  • Dietary supplementCarbohydrate shake

    22oz of a carbohydrate drink containing 320 kilocalories (75g carbohydrate, 3g protein, \<1g fat)

06

What researchers measure

Primary outcomes

  1. Metabolic Heat Production

    Heat production measured during exercise at 6 watts/kg, calculated based on oxygen consumption and carbon dioxide production during exercise (indirect calorimetry)

    Time frame: Measured during 60 minutes of steady state exercise in 36C, 40% humidity

Secondary outcomes

  1. Core Temperature

    Internal temperature change during exercise

    Time frame: Measured at rest and following 60 minutes of exercise in a warm (36C, 40% humidity) environment

  2. Urinary NGAL (ng/mL)

    Measured after exercise in high-protein and high-carbohydrate trials, NGAL (neutrophil-gelatinase associated lipocalin; a marker of acute kidney injury) will be measured in urine samples in each trial to assess kidney function.

    Time frame: Following 60 minutes of exercise in a warm environment (36C, 40% relative humidity)

  3. Urine Specific Gravity (USG)

    Measured in urine samples provided before and after exercise, USG will be used as a marker of urine concentration and hydration status with each intervention.

    Time frame: Measured before and after 60 minutes of exercise in a warm (36C, 40%RH) environment.

  4. Proteinuria

    Measured after exercise in high-protein and high-carbohydrate trials, total protein content will be measured in urine samples in each trial to assess kidney function.

    Time frame: Following 60 minutes of exercise in a warm environment (36C, 40% relative humidity)

07

Study locations

No study locations are listed for this record.

08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jun 2026; primary completion for May 2027, 11 months later.

Of 77 non-industry interventional studies with no phase under Heat Stress Disorders, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 27. This study's planned 11 months is below that.

Counting every sponsor, half of 77 studies reached it within 14 months; a quarter within 5 and three quarters within 27.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 2, 2026
First posted
Jun 15, 2026
StartEst.
Jun 4, 2026
Primary completionEst.
May 2027
CompletionEst.
May 2027
Last update
Jun 15, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 15, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07646990
Lead sponsor
Providence College
Responsible party
Brett Romano Ely (Assistant Professor of Health Sciences, Providence College) — Principal investigator
First posted
Jun 15, 2026
Start date
Jun 4, 2026 (estimated)
Primary completion
May 2027 (estimated)
Completion
May 2027 (estimated)
Last update
Jun 15, 2026

Study contacts

Brett R Ely, PhD
Contact
bely@providence.edu
401-865-2632
Margaret Morrissey-Basler, PhD
Contact
mmorri17@providence.edu
401-865-1209

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion